References
Bovet P, Hirsiger P, Emery F, De Bernardini J, Rossier C, Trebeljahr J, Hagon-Traub I (2011) Impact and cost of a 2-week community-based screening and awareness program for diabetes and cardiovascular risk factors in a Swiss canton. Diabetes Metab Syndr Obes 4:213–223
Hagon-Traub I, Hirsiger P, Bovet P, Ruiz J, Peytremann-Bridevaux I, Noth C, Hauschild (2010) Programme cantonal Diabète, présentation du programme. Lausanne: Service de la Santé Publique du canton de Vaud. http://www.vd.ch/fileadmin/user_upload/themes/sante_social/services_soins/Diabete/fichiers_pdf/Programme_cantonal.pdf
Hersberger KE, Botomino A, Mancini M, Bruppacher R (2006) Sequential screening for diabetes—evaluation of a campaign in Swiss community pharmacies. Pharm World Sci 28:171–179
Knoester PD, Belister SV, Deckers CLP, Keyser A, Renier WO, Egberts ACG, Hekster YA (2005) Recruitment of a cohort of lamotrigine users through community pharmacists: differences between patients who gave informed consent and those who did not. Pharmacoepidemiol Drug Saf 14:107–112
McLean DL, McAlister FA, Johnson JA, King KM, Makowsky MJ, Jones CA, Tsuyuki RT, SCRIP-HTN Investigators et al (2008) A randomized trial of the effect of community pharmacist and nurse care on improving blood pressure management in patients with diabetes mellitus: study of cardiovascular risk intervention by pharmacists-hypertension (SCRIP-HTN). Arch Intern Med 168:2355–2361
Nolte E, Knai C, McKee M (2008) Managing chronic conditions: experience in eight countries. World Health Organization on behalf of the European Observatory on Health Systems and Policies, Copenhagen
Santschi V, Chiolero A, Burnand B, Colosimo AL, Paradis G (2011) Impact of pharmacist care in the management of cardiovascular disease risk factors: a systematic review and meta-analysis of randomized trials. Arch Intern Med 171:1441–1453
Van Wieren-de Wijer DB, Maitland-van der Zee AH, de Boer A, Stricker BH, Kroon AA, de Leeuw PW, Bozkurt O, Klungel OH et al (2009) Recruitment of participants through community pharmacies for a pharmacogenetic study of antihypertensive drug treatment. Pharm World Sci 31:158–164
Acknowledgments
We would like to thank all pharmacies, diabetic patients and practicing physicians who participated in the study. We also thank the partners and members of the working group for their collaboration. We thank Mrs. Lucienne Boujon for copy editing the manuscript. This study was funded by the Department of Public Health of the canton of Vaud. Dr. I. Peytremann-Bridevaux is supported by a grant from the Swiss National Science Foundation [PROSPER N° 32333B-123817 and N° 32333B-139789].
Conflict of interest
None of the authors has conflict of interest to declare.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Peytremann-Bridevaux, I., Bordet, J., Santschi, V. et al. Community-based pharmacies: an opportunity to recruit patients?. Int J Public Health 58, 319–322 (2013). https://doi.org/10.1007/s00038-012-0383-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00038-012-0383-8